Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1029-1033. doi: 10.19723/j.issn.1671-167X.2020.06.007

Previous Articles     Next Articles

Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection

Guo TANG1,Li LONG2,(),Ya-xin HAN3,Qing PENG4,Jia-jun LIU4,Hua SHANG4   

  1. 1. Department of Rheumatology and Immunology, The Bishan Hospital of Chongqing, Chongqing 402760, China
    2. Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, Chengdu 610000, China
    3. Department of Rheumatology and Immunology, The People’s Hospital of Wenjiang, Chendu 610000, China
    4. The First Clinical Institute, Zunyi Medical University, Zunyi 563000, Guizhou, China
  • Received:2020-07-30 Online:2020-12-18 Published:2020-12-13
  • Contact: Li LONG E-mail:llllyyyy2012@sina.com

RICH HTML

  

Abstract:

Objective: To investigate the clinical characteristics and high risk factors of Rheumatoid arthritis (RA) complicated with tuberculosis infection. Methods: Patients with rheumatoid arthritis diagnosed in the hospital of Sichuan Provincial People’s Hospital from January 2007 to January 2017 was retrospectively collected, who were enrolled in the study group. A control group was randomly selected from the RA patients hospitalized in the same period without co-infection at a ratio of 1:2. The general data, clinical data, laboratory test data, treatment plan, etc. of the two groups were collected in detail for single factor statistical analysis. Then multivariate Logistic regression was used to analyze the independent risk factors of RA complicated with tuberculosis infection with statistical significance in univariate analysis. Results: The clinical manifestations of fever (83.3%) were most common, followed by cough (69%) and body mass loss (45.2%). In the infected group, pulmonary tuberculosis accounted for 73.3%. In the infected group the chest CT showed two or more cases, accounting for 59%. There were 9 cases (33.3%) occurring in the typical tuberculosis occurrence site. Compared with the control group, the erythrocyte sedimentation rate (ESR), C-reaction protein (CRP) levels, and the daily average dose of glucocorticoid in 1 year in the infected group were higher than those in the control group. And those differences were statistically significant(P<0.05). There were no significant differences in gender, age, disease duration, disease activity score, white blood cell (WBC), platelet (PLT), hemoglobin (Hb), immunoglobulin G (IgG), complement (C), Anti cyclic citrullinated peptide antibody (anti-CCP), CD4+T cell count, and immunosuppressant use (P>0.05). Multivariate Logistic regression analysis showed that CRP levels(OR=1.016, 95%CI:1.002-1.031) and the daily average dose of glucocorticoid in 1 year(OR=1.229, 95%CI:1.066-1.418)were the independent risk factors of RA complica-ted with tuberculosis infection. Conclusion: RA patients with tuberculosis infection are mainly phthisis. The clinical manifestations of RA combined with tuberculosis infection are lack of specificity, and the chest imaging features of pulmonary tuberculosis are diverse, which are easy to be misdiagnosed. CRP levels and the daily average dose level of glucocorticoid in 1 year were risk factors for RA and tuberculosis infection.

Key words: Rheumatoid arthritis, Tuberculosis, Risk factor

CLC Number: 

  • R593

Table 1

Multivariate Logistic regressionanalysis of the related factors of RA complicated with tuberculosis"

Characteristic B SE P OR (95%CI)
CRP 0.016 0.007 0.030 1.016 (1.002, 1.031)
ESR 0.008 0.011 0.486 1.008 (0.986, 1.030)
Average daily dose of glucocorticoid 0.206 0.073 0.005 1.229 (1.066, 1.418)
[1] Justin L, Warren F, Wijaya L, et al. Disseminated tuberculosis masquerading as a presentation of systemic lupus erythematosus[J]. Int J Rheum Dis, 2018,21(1):352-355.
pmid: 28971575
[2] World Health Organization. Global Tuberculosis Report 2019[EB/OL].(2019-12-12)[2020-04-10]. https://www.who.int/tb/publications/global_report/en.
[3] 刘二勇, 周林, 成诗明. 结核分枝杆菌潜伏性感染及预防性治疗研究进展的系统评价[J]. 中国防痨杂志, 2013,35(4):231-239.
[4] Chung T, Ko H, Lau C, et al. A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis[J]. Rheumatol Int, 2020,40(6):983-990.
pmid: 32318800
[5] Christy H, Mike O, Jessie B, et al. Finding the missing patients with tuberculosis: lessons learned from patient-pathway analyses in 5 countries[J]. J Infect Dis, 2017,216(7):686-695.
[6] Handa R, Upadhyaya S, Kapoor S, et al. Tuberculosis and biologics in rheumatology: A special situation[J]. Int J Rheum Dis, 2017,51(10):115.
[7] Chin DP, Hanson C L. Finding the missing tuberculosis patients[J]. J Infect Dis, 2017,216(7):675-678.
[8] Balsa A, Carmona L, González-Alvaro I, et al. Value of disease activity score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.[J]. J Rheumatol, 2004,31(1):40.
pmid: 14705217
[9] 中华人民共和国国家卫生健康委员会. 结核病分类(WS196—2017)[J]. 新发传染病电子杂志, 2018,3(3):191-192.
[10] 中华人民共和国国家卫生健康委员会. 肺结核诊断标准(WS 288—2017)[J]. 新发传染病电子杂志, 2018,3(1):59-61.
[11] Franco MD, Lucchino B, Spaziant M, et al. Lung infections in systemic rheumatic disease: focus on opportunistic infections.[J]. Int J Mol Sci, 2017,18(2):293.
[12] Ni Mhuircheartaigh OM, Matteson EL, Green AB, et al. Trends in serious infections in rheumatoid arthritis[J]. J Rheumatol, 2013,40(5):611-616.
doi: 10.3899/jrheum.121075 pmid: 23547208
[13] Anton C, Machado FD, Ramirez JMA, et al. Latent tuberculosis infection in patients with rheumatic diseases[J]. J Bras Pneumol, 2019,45(2):e20190023.
doi: 10.1590/1806-3713/e20190023 pmid: 31038654
[14] 邓国防, 王玉香, 陈涛, 等. 风湿免疫性疾病并发结核感染的临床特征分析[J]. 中国防痨杂志, 2018,40(4):392-396.
[15] Hong LC, Hsin-Hua C, Yi-Hsing C, et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.[J]. PLoS One, 2017,12(6):e0178035.
doi: 10.1371/journal.pone.0178035 pmid: 28570568
[16] Youssef J, Novosad SA, Winthrop KL, et al. Infection risk and safety of corticosteroid use[J]. Clin Rheum Dis, 2016,42(1):157-176.
[1] Qingxian LUAN. To create the era of oral health management in China [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 244-246.
[2] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[3] Jie ZHAO, Chun FU, Xiujuan ZHAO, Haiyan XUE, Shu LI, Zhenzhou WANG, Fengxue ZHU. Risk factors for ventilator-associated pneumonia in patients with chest trauma in intensive care unit [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 351-358.
[4] Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031.
[5] Yan DING, Lifang WANG, Chaoran LI, Zhemin LU, Lianjie SHI. Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1203-1207.
[6] Ju YANG, Jing XU, Juhua DAI, Lianjie SHI. Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 911-918.
[7] Lianghua FENG, Lirong HONG, Yujia CHEN, Xueming CAI. Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 919-925.
[8] Bowen LI, Qiang ZHANG, Yixin SUN. Establishment and validation of a risk prediction model for scoliosis after Nuss procedure in children and young adults with pectus excavatum [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 941-946.
[9] Xiaoyong YANG, Fan ZHANG, Lulin MA, Cheng LIU. Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 956-960.
[10] Wei LIU, Wen GUO, Zhe GUO, Chunyan LI, Yunlong LI, Siqi LIU, Liang ZHANG, Hui SONG. Risk factors associated with non-radiographic bone erosion in patients with gout [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 735-739.
[11] Mengxi LU, Qiuping LIU, Tianjing ZHOU, Xiaofei LIU, Yexiang SUN, Peng SHEN, Hongbo LIN, Xun TANG, Pei GAO. Association of triglyceride-glucose index and cardiovascular disease in a community-based Chinese cohort [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 430-435.
[12] Shuhan YANG, Yixin LI, Haoliang CUI, Youxin WANG, Yuying WU, Mingyue WANG, Yifan YANG, Nur Enkar, Lei YANG, Hui WANG. Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 487-495.
[13] Longao YANG, Xu JIN, Wenchu HUANG, Lihua HE, Juan CHEN. Epidemiological investigation of asthenopia and dry eye among visual display terminal workers [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 554-561.
[14] Huaqiu GUO, Zhe WANG, Xue YANG, Jie BAI. Clinical features and risk factors of patients with oral bleeding in dental emergency [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 142-147.
[15] Minting DENG, Nan WANG, Bin XIA, Yuming ZHAO, Junxia ZHU. Factors associated with spontaneous re-eruption of traumatically intruded permanent anterior teeth in children and adolescents [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 148-153.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!